Richter Gedeon Vegyeszeti Gyar Rt

Biorex Kutato-fejleszto Kft

Folligen Budapest Ltd.

Fitorex Kft.

Fitorex Group Kft.

Jeno Szilbereky

Bela Stefko

Maria Boross

Janos Kreidl

Gizella Zsila

Peter L Nagy

Eva Csizer

Peter Turcsanyi

Szilard Vezer

Bela Balazs

Gyorgy Blasko

Attila Almasi

Bela Gachalyi

Gabor Nemet

Erik Bogsch

Judit M Meszaros Nee Brill

Jozsef Bakos

Ida Deutsch Nee Juhasz

Balint Heil

Laszlo Szotyori

Lajos Braham

Andrea Jednakovits

Andras Salgo

Gabor Barla Szabo

Gabor Nemeth

Ildiko Szilagyi

Zsuzsanna Aracs Nee Trischler

Peter N Literati

Istvan Greiner

Ida Nee Deutsch

Gyorgy Thaler

Lajos Abraham

Zsuzsanna Aracs

Judit Meszaros

Zsuzsanna Arcs Nee Trischler

Laszlo Szabados

Gaborne Barla Szabo

Gábor Barla SzabÓ

András SalgÓ

László Szabados

Andrea JEDNÁKOVITS

Hydroximic acid derivatives of the formula ##STR1## These compounds are useful for treating diabetes angiopathy.

0-(3-amino-2-hydroxypropyl)-hydroximic acid halides and process for

O-(3-amino-2-hydroxypropyl)-hydroximic acid halides and process for

Polyunsaturated fatty acid derivatives, pharmaceutical compositions

A process for the dehydration of substances, mixtures, primarily condensation reaction mixtures, (e.g. direct esterification, direct acetal formation, direct ketal formation), performed by continuous azeotropic distillation with an organic solvent forming with water an azeotropic mixture of minimal boiling point and unable to mix with water, carried out in such a way that the distillate is cooled at least to the temperature, at which the condensate with the given water content or the organic phase of the condensate is just supersaturated with respect to water, and the organic phase of lower water content obtained in this way is recycled to the distilling boiler. The organic solvents used are e.g. benzene, toluene, 1,2-dichloroethane, chloroform, carbon tetrachloride.

Process for dehydration of condensation reaction mixtures obtained by

An antifungal or anthelmintic method of treatment is disclosed which comprises the step of administering to a mammal in need of said treatment, a pharmaceutically effective amount of a compound of the Formula (I) ##STR1## wherein X is halogen, C.sub.1 to C.sub.6 alkoxy, or a group --NRR.sup.1 in which R and R.sup.1 are each hydrogen or C.sub.1 to C.sub.6 alkyl; and

Aminodiaryl sulfoxide derivatives, process for their preparation and

The invention relates to a new process for the preparation of aminodiaryl sulfoxide derivatives of the formula (I), ##STR1## wherein X is halogen, alkoxy having from 1 to 6 carbon atoms or a group --(N,R,R.sup.1), in which p1 R and R.sup.1 are hydrogen or alkyl having from 1 to 6 carbon atoms,

Process for the preparation of nitrodiaryl sulfoxides

The invention relates to a new process for the preparation of aminodiaryl sulfoxide derivatives of the formula (I), ##STR1## wherein X is halogen, alkoxy having from 1 to 6 carbon atoms or a group --(N,R,R.sup.1), in which

Nitrodiaryl sulfoxide derivatives, process for their preparation and

Growing community of inventors

Budapest, Hungary

Jeno Szilbereky